Clinical trials are being reimagined—smarter, faster, and truly patient-first. From AI and automation to digital biomarkers and next-gen data strategies, technology is transforming every stage of the trial process. Our Congress Themes sessions explore the breakthroughs driving precision, speed, and better outcomes for patients everywhere.
Our keynote sessions set the tone for the entire congress, bringing together thought leaders from leading organizations
to share their vision of how technology is transforming the clinical trial landscape. These high-level talks focus on
company-wide transformation and change, exploring how to adopt emerging technologies and embrace innovative trial
models that drive smarter clinical development.
Speakers:
Johannes Streffer, SVP, Global Clinical Development, Lundbeck
Sid Jain, SVP, Clinical Development & Data Science, Recursion
David Carruthers, Vice President BioPharmaceuticals R&D Clinical Operations, AstraZeneca
Samantha Warden, VP & Global Head Clinical Programming & Business Excellence, GSK
Liz Nevin, Executive Director R&D IT, E2E R&D, AstraZeneca
Matthew Bonam, VP, Head of BioPharmaceuticals R&D Digital Patient Health & Innovation, AstraZeneca
The Connected Patient
“Putting the patient at the centre of every trial”
This session explores how digital innovation not only broadens access, but also improves patient matching,
optimizes study workflows, and delivers richer insights to drive better outcomes.
AI-Driven Site and Participant Matching
Relieving the patient burden
How are novel technologies enabling decentralized trial design and execution?
Advanced wearables and sensors for continuous, real-world monitoring of patient behaviour and disease progression
Overcoming geographic limitations using virtual site technology
Digital platforms for patient co-design to shape trial protocols and improve experience
How can digital interfaces and support tools enable flexible patient participation?
Generating real-time safety alerts triggered by biometric data
Speakers:
Nadir Ammour, Global Lead Clinical Innovation and External Partnerships, Sanofi
Clara Cali Mella, Senior Analytics and Insights Manager, Bayer Pharma
Chrissie Fletcher, VP Respiratory, Immunology and Inflammation Statistics, Biostatistics, GSK
Nicola Götz, Global Biostatistics & Data Sciences, Boehringer Ingelheim
Isabela Niculae, Head Clinical Innovation and Digital Solutions / Global Clinical Operations, UCB
Hassan Khalid, Director – Senior Engineer, Machine Learning and Data Science, AstraZeneca
Digital Biomarkers
“Sharpening endpoints, boosting safety”
This session will explore the latest innovations, real-world applications, and strategies for integrating
digital biomarkers into clinical trial design.
Capturing real-time patient insights without disrupting daily life to enhance trial efficiency and compliance
Validating new digital biomarkers
How can digital signals be used to identify disease markers sooner?
Integration of digital biomarkers with traditional data sources
How to utilise a range of biomarker types to support personalised medicine
Speakers:
Christian Gossens, Digital Biomarkers Chapter Lead, Roche
Teske Valk, Senior International Medical Manager, Novo Nordisk
Davide Carluccio, Principal Global Clinical Operations Manager, Almirall
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
